This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Kelly H Dodge: Innovator in Antibody Research
Introduction
Kelly H Dodge is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work has implications for therapeutic applications, showcasing her expertise and dedication to innovation.
Latest Patents
Kelly H Dodge holds a patent for "Antibodies to DcR3 Polypeptide, a TNFR Homolog." This patent involves a TNFR homolog identified as DcR3. It includes nucleic acid molecules encoding DcR3, chimeric molecules, and antibodies to DcR3. This invention represents a critical advancement in understanding and utilizing TNFR homologs in medical research.
Career Highlights
Kelly is associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative therapies. Her role at Genentech has allowed her to contribute to groundbreaking research and development in the field of antibodies.
Collaborations
Throughout her career, Kelly has collaborated with notable scientists, including Avi J Ashkenazi and David Botstein. These collaborations have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Kelly H Dodge is a remarkable inventor whose work in antibody research continues to influence the field of biotechnology. Her contributions, particularly her patent on DcR3, highlight her role as a leader in innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile